Drawing for ONCIRE

USPTO serial 79188740

ONCIRE

Reviewed by CopyMark Law Group

Reg. 5070824Status 709
Filing date
Status date
Registration date
Nov 1, 2016
Examiner
POLZER, NATALIE M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ONCIRE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibioticsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 18, 2024INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jan 29, 2024INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jan 29, 2024INPCINVALIDATION PROCESSED—
Jan 12, 2024INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 12, 2023C71TCANCELLED SECTION 71—
Dec 16, 2016GPNXNOTIFICATION PROCESSED BY IB—
Dec 1, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 1, 2016FIMPFINAL DISPOSITION PROCESSED—
Dec 1, 2016GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Nov 25, 2016OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 1, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 16, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 10, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 10, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 27, 2016NPUBNOTICE OF PUBLICATION—
Jul 15, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 12, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 11, 2016DOCKASSIGNED TO EXAMINER—
Jul 11, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 8, 2016LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jul 7, 2016SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance